Moreover, BPIFB1-positive NPC is associated with longer progression-free survival and overall survival compared to that of BPIFB1-negative NPC in similarly classified patients administered the same dose of radiotherapy11. Here, BPIFB1 is linked to nasopharyngeal carcinoma.